Hørsholm, Denmark, 13 November 2012 -- Pursuant to section 29 of the Danish Securities Trading Act, Veloxis Pharmaceuticals A/S (OMX: VELO) hereby makes public, that the company has received the following major shareholder announcements:
Hørsholm, Denmark, 13 November 2012 -- Pursuant to section 29 of the Danish Securities Trading Act, Veloxis Pharmaceuticals A/S (OMX: VELO) hereby makes public, that the company has received the following major shareholder announcements:
